Bloomberg the Company

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Follow Us

Industry Products

  • Exchange: OTC US
  • Sector: Technology
  • Industry: Technology Services
  • Sub-Industry: Information Services

DIAGNOS Inc/Canada

+ Add to Watchlist

DGNOF:US

0.0430 USD 0.0068 18.78%

As of 20:10:01 ET on 01/26/2015.

Snapshot for DIAGNOS Inc/Canada (DGNOF)

Open: 0.0430 Day's Range: 0.0430 - 0.0430 Volume: 7,720
Previous Close: 0.0362 52wk Range: 0.0318 - 0.1060 1-Yr Rtn: -60.91%

Stock Chart for DGNOF

No chart data available.
  • DGNOF:US 0.0430
  • 1D
  • 1M
  • 1Y
0.0362
Interactive DGNOF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for DGNOF

Current P/E Ratio (ttm) -
Estimated P/E(-) -
Relative P/E vs. SPX -
Earnings Per Share (ttm) -
Est. EPS -
Est. PEG Ratio -
Market Cap (M USD) 4.56
Shares Outstanding (M) 106.15
30 Day Average Volume 12,807
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for DGNOF

  • Revenue
  • Net Income (M/CAD)
  • Profit Margin (%)

Company Profile & Key Executives for DGNOF

Diagnos Inc. of Canada develops and publishes a knowledge extraction platform that allows for the enhancement and intelligent analysis of digital images. The company targets these applications to the field of medicine, specifically for the detection of Diabetes, AMD and Glaucoma, through the enhanced analysis of retinal images.

Andre LarentePresidentHoussem Ben TaharVP:Dev & Bus Intelligence
Marc-Andre MassueVP:Finance/CFO/Secretary
More Company Profile & Key Executives for DGNOF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil